Advertisement

Journal of Clinical Immunology

, Volume 33, Issue 6, pp 1062–1066 | Cite as

B-Cell Lymphoma in a Patient with Complete Interferon Gamma Receptor 1 Deficiency

  • Hannelore I. Bax
  • Alexandra F. Freeman
  • Victoria L. Anderson
  • Per Vesterhus
  • Dan Laerum
  • Stefania Pittaluga
  • Wyndham H. Wilson
  • Steven M. Holland
Astute Clinician Report

Abstract

Immunosuppression-associated lymphoproliferative disorders can be related to primary as well as acquired immune disorders. Interferon gamma receptor (IFN-γR) deficiency is a rare primary immune disorder, characterized by increased susceptibility to mycobacterial infections. Here we report the first case of an Epstein Barr Virus (EBV) related B-cell lymphoma in a patient with complete IFN-γR1 deficiency. The patient was a 20-year-old man with homozygous 22Cdel in IFNGR1 resulting in complete absence of IFN-γR1 surface expression and complete lack of responsiveness to IFN-γ in vitro. He had disseminated refractory Mycobacterium avium complex and Mycobacterium abscessus infections. At age 18 he presented with new spiking fever and weight loss that was due to an EBV-positive B-cell non-Hodgkin lymphoma. Two years later he died of progressive lymphoma. IFN-γ plays an important role in tumor protection and rejection. Patients with IFN-γR deficiencies and other immune deficits predisposing to mycobacterial disease seem to have an increased risk of malignancies, especially those related to viral infections. As more of these patients survive their early infections, cancer awareness and tumor surveillance may need to become a more routine part of management.

Keywords

B-cell lymphoma interferon gamma receptor deficiency 

Notes

Conflict of interest

The authors declare that they have no conflicts of interest.

References

  1. 1.
    de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, et al. Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries. Med (Baltimore). 2010;89(6):381–402.CrossRefGoogle Scholar
  2. 2.
    Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Baretto R, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet. 2004;364(9451):2113–21.CrossRefPubMedGoogle Scholar
  3. 3.
    Roesler J, Kofink B, Wendisch J, Heyden S, Paul D, Friedrich W, et al. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp Hematol. 1999;27(9):1368–74.CrossRefPubMedGoogle Scholar
  4. 4.
    Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis. 2005;41(4):e38–41.CrossRefPubMedGoogle Scholar
  5. 5.
    Vinh DC, Masannat F, Dzioba RB, Galgiani JN, Holland SM. Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency. Clin Infect Dis. 2009;49(6):e62–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Roesler J, Hedrich C, Laass MW, Heyne K, Rosen-Wolff A. Meningoencephalitis caused by varicella-zoster virus reactivation in a child with dominant partial interferon-gamma receptor-1 deficiency. Pediatr Infect Dis J. 2011;30(3):265–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Camcioglu Y, Picard C, Lacoste V, Dupuis S, Akcakaya N, Cokura H, et al. HHV-8-associated Kaposi sarcoma in a child with IFNgammaR1 deficiency. J Pediatr. 2004;144(4):519–23.CrossRefPubMedGoogle Scholar
  8. 8.
    Dorman SE, Uzel G, Roesler J, Bradley JS, Bastian J, Billman G, et al. Viral infections in interferon-gamma receptor deficiency. J Pediatr. 1999;135(5):640–3.CrossRefPubMedGoogle Scholar
  9. 9.
    Hambleton S, Salem S, Bustamante J, Bigley V, Boisson-Dupuis S, Azevedo J, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med. 2011;365(2):127–38.CrossRefPubMedGoogle Scholar
  10. 10.
    Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653–5.Google Scholar
  11. 11.
    Bustamante J, Arias AA, Vogt G, Picard C, Galicia LB, Prando C, et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol. 2011;12(3):213–21.CrossRefPubMedGoogle Scholar
  12. 12.
    Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, et al. Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science. 2012;337(6102):1684–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Oertel SH, Riess H. Immunosurveillance, immunodeficiency and lymphoproliferations. Recent Results Cancer Res. 2002;159:1–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Bonnet F, Chene G. Evolving epidemiology of malignancies in HIV. Curr Opin Oncol. 2008;20(5):534–40.CrossRefPubMedGoogle Scholar
  15. 15.
    Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF. HIV-associated lymphomas and gamma-herpesviruses. Blood. 2009;113(6):1213–24.CrossRefPubMedGoogle Scholar
  16. 16.
    Parker A, Bowles K, Bradley JA, Emery V, Featherstone C, Gupte G, et al. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines. Br J Haematol. 2010;149(5):675–92.CrossRefPubMedGoogle Scholar
  17. 17.
    Tran H, Nourse J, Hall S, Green M, Griffiths L, Gandhi MK. Immunodeficiency-associated lymphomas. Blood Rev. 2008;22(5):261–81.CrossRefPubMedGoogle Scholar
  18. 18.
    Lugo Reyes SO, Suarez F, Herbigneaux RM, Pacquement H, Reguerre Y, Riviere JP, et al. Hodgkin lymphoma in 2 children with chronic granulomatous disease. J Allergy Clin Immunol. 2011;127(2):543-4 e1–3.CrossRefGoogle Scholar
  19. 19.
    Holland SM, Dorman SE, Kwon A, Pitha-Rowe IF, Frucht DM, Gerstberger SM, et al. Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency. J Infect Dis. 1998;178(4):1095–104.CrossRefPubMedGoogle Scholar
  20. 20.
    Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163–89.CrossRefPubMedGoogle Scholar
  21. 21.
    Dunn GP, Ikeda H, Bruce AT, Koebel C, Uppaluri R, Bui J, et al. Interferon-gamma and cancer immunoediting. Immunol Res. 2005;32(1–3):231–45.CrossRefPubMedGoogle Scholar
  22. 22.
    Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, et al. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol. 1994;153(4):1697–706.PubMedGoogle Scholar
  23. 23.
    Street SE, Trapani JA, MacGregor D, Smyth MJ. Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J Exp Med. 2002;196(1):129–34.CrossRefPubMedGoogle Scholar
  24. 24.
    Critchley-Thorne RJ, Simons DL, Yan N, Miyahira AK, Dirbas FM, Johnson DL, et al. Impaired interferon signaling is a common immune defect in human cancer. Proc Natl Acad Sci U S A. 2009;106(22):9010–5.CrossRefPubMedGoogle Scholar
  25. 25.
    Duncan TJ, Rolland P, Deen S, Scott IV, Liu DT, Spendlove I, et al. Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancer. Clin Cancer Res. 2007;13(14):4139–45.CrossRefPubMedGoogle Scholar
  26. 26.
    Garcia-Tunon I, Ricote M, Ruiz AA, Fraile B, Paniagua R, Royuela M. Influence of IFN-gamma and its receptors in human breast cancer. BMC Cancer. 2007;7:158.CrossRefPubMedGoogle Scholar
  27. 27.
    Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A. 1998;95(13):7556–61.CrossRefPubMedGoogle Scholar
  28. 28.
    Ikeda H, Old LJ, Schreiber RD. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 2002;13(2):95–109.CrossRefPubMedGoogle Scholar
  29. 29.
    Lu Y, Yang W, Qin C, Zhang L, Deng J, Liu S, et al. Responsiveness of stromal fibroblasts to IFN-gamma blocks tumor growth via angiostasis. J Immunol. 2009;183(10):6413–21.CrossRefPubMedGoogle Scholar
  30. 30.
    Smyth MJ, Thia KY, Street SE, MacGregor D, Godfrey DI, Trapani JA. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med. 2000;192(5):755–60.CrossRefPubMedGoogle Scholar
  31. 31.
    Takeda K, Hayakawa Y, Smyth MJ, Kayagaki N, Yamaguchi N, Kakuta S, et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med. 2001;7(1):94–100.CrossRefPubMedGoogle Scholar
  32. 32.
    Toyoda H, Ido M, Nakanishi K, Nakano T, Kamiya H, Matsumine A, et al. Multiple cutaneous squamous cell carcinomas in a patient with interferon gamma receptor 2 (IFN gamma R2) deficiency. J Med Genet. 2010;47(9):631–4.CrossRefPubMedGoogle Scholar
  33. 33.
    van de Vosse E, Hoeve MA, Ottenhoff TH. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis. 2004;4(12):739–49.CrossRefPubMedGoogle Scholar
  34. 34.
    Kong XF, Vogt G, Chapgier A, Lamaze C, Bustamante J, Prando C, et al. A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon. Hum Mol Genet. 2010;19(3):434–44.CrossRefPubMedGoogle Scholar
  35. 35.
    Sologuren I, Boisson-Dupuis S, Pestano J, Vincent QB, Fernandez-Perez L, Chapgier A, et al. Partial recessive IFN-gammaR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds. Hum Mol Genet. 2011;20(8):1509–23.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York (outside the USA) 2013

Authors and Affiliations

  • Hannelore I. Bax
    • 1
    • 2
  • Alexandra F. Freeman
    • 1
  • Victoria L. Anderson
    • 1
  • Per Vesterhus
    • 3
  • Dan Laerum
    • 4
  • Stefania Pittaluga
    • 5
  • Wyndham H. Wilson
    • 6
  • Steven M. Holland
    • 1
  1. 1.Laboratory of Clinical Infectious DiseasesNational Institute of Allergy and Infectious Diseases, National Institutes of HealthBethesdaUSA
  2. 2.Department of Internal Medicine, Division of Infectious DiseasesErasmus Medical CenterRotterdamthe Netherlands
  3. 3.Department of PaediatricsSorlandet Hospital KristiansandKristiansandNorway
  4. 4.Internal Medicine, Division of PulmonologySorlandet Hospital KristiansandKristiansandNorway
  5. 5.Laboratory of PathologyNational Cancer Institute, NIHBethesdaUSA
  6. 6.Metabolism BranchNational Cancer Institute, NIHBethesdaUSA

Personalised recommendations